Phase
Condition
Circulation Disorders
Lung Injury
Pulmonary Arterial Hypertension
Treatment
95% - 99% SpO2 target
Clinical Study ID
Ages < 28 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Corrected gestational age (postmenstrual age) > 34 6/7 weeks
postnatal age ≤ 28 d
on respiratory support with invasive mechanical ventilation, non-invasiveventilation, CPAP or high flow nasal cannula (defined as flow rates ≥ 2 LPM with ahumidifier), inspired oxygen concentration, FiO2 ≥ 0.3
and echocardiography shows any finding suggestive of PH (or score > 0 for PH intable 2).
Infants with congenital diaphragmatic hernia (CDH), Down syndrome, hypoxic ischemicencephalopathy (HIE) on therapeutic hypothermia and patent ductus arteriosus (PDA),patent foramen ovale/atrial septal defect (PFO/ASD) and ventricular septal defect (VSD) (single or multiple) < 2 mm can be included in the study.
Exclusion
Exclusion Criteria:
< 32 weeks gestation at birth (31 6/7 or lower)
Weight < 2000 g at the time of enrollment
Severe HRF with OI > 35 or SpO2 < 75% on FiO2 = 1.0 on mechanical ventilation for > 60 minutes in spite of correction of reversible factors such as pneumothorax
A condition or congenital anomaly known to be lethal (high likelihood of deathduring infancy) - e.g., trisomy 18 or trisomy 13
Congenital heart disease other than ASD/PFO, PDA or VSD (single or multiple defects) < 2 mm.
Study Design
Study Description
Connect with a study center
University of California-Davis
Sacramento, California 95817
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.